ARCHIMED
Adrian Bjorndahl is an accomplished finance professional with extensive experience in investor relations and financial analysis. Currently serving as the Associate Director of Investor Relations for EMEA at ARCHIMED since April 2022, Adrian has previously held roles as an Associate at Reach Capital, an Investor Relations Analyst at Access Capital Partners, and an M&A Analyst at CFK Finance - Groupe INTERACTIS. Early career experience includes a position as a Financial Analyst at SQ2 dvp. Adrian has an academic background from Menlo College and SKEMA Business School.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.